Hexarelin

Also known as: Examorelin, EP-23905

Growth Hormone

Phase I

Hexarelin is the most potent of the GHRP-class growth hormone releasing peptides, producing the largest GH pulses of any synthetic secretagogue studied. It also has unique cardioprotective properties that are independent of GH release, acting directly on cardiac tissue via CD36 and GHS-R1a receptors.

Regulatory & Approval Status

Not FDA Approved

Hexarelin is a synthetic growth hormone secretagogue that has undergone limited early-phase human trials but remains a research-only compound without FDA approval.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.